Concord Biotech shares gain 6% after USFDA approval for Tofacitinib tablets
Shares of Concord Biotech rose over 6% to their day’s high of Rs 1,350 on the BSE on Wednesday after ...
Wednesday, July 22, 2026
Tag: Tofacitinib
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.